Informational Links

Studies

2005 - 2009: FDA Phase II Clinical Trials - Ranibizumab (Lucentis) in the Treatment of Macular Degeneration, Sea Horizon Study, Genentech

July 2005 – June 2008: FDA Phase IIIB Extension Study - Ranibizumab (Lucentis) in the treatment of Choroidal Neovascularization secondary to Age-Related Macular Degeneration, Genentech

April 2004 – March 2006: FDA Phase III Clinical Trials - Posurdex in the treatment of Retinal Vascular Occlusive Disease, Allergan

June 2003 - November 2006: FDA Phase II Clinical Trials - Rhufab in Macular Degeneration, Genentech Corporation, Anchor Study

March 2003 - November 2006: FDA Phase II Clinical Trials - Rhufab in Macular Degeneration, Genentech Corporation, Marina Study

2002 - 2004: CMV Retinitis and Viral Resistance Study: Sub-Investigator. Bascom Palmer Eye Institute, Miami, Florida

1999 - 2000: FDA Phase III Clinical Trials - Visudyne (Verteporfin) in the Treatment of Age Related Macular Degeneration, Johns Hopkins University

Publications & Presentations

By Doctor James A. Staman:
“EOG and Choroidal Melanomas.” Documenta Ophthalmologica, 1979

“Surgical Correction of Circumferential Folds of Giant Tears.” Retina, Volume 1, Number 1, 1980

By Doctor Thomas A. Barnard:
“Metallic Intraocular Object Simulating Foreign Body” case report with Daniel T. Weidenthal, M.D.: American Journal of Ophthalmology, July 1998

“Bilateral Metastatic Menignococcal Endophthalmitis” case report with Arup Das, M.D., University of New Mexico: Archives of Ophthalmology, November 1997

“Endogenous Endophthalmitis” clinical case and literature review presented at Saint Luke’s Medical Center House Staff Science Day with Daniel T. Weidenthal, M.D., 1997

“Comparison of diabetic vs. pseudophakic disc staining, with Peter Pavan, M.D.; University of South Florida, 1992

“The addition of alkanes to 1-methylcyclohexene using Lewis acids”; under the direction of Theodore Beiler, Stetson University, 1987

By Doctor John P. Sullivan:
“Management of Cataract Patients with Significant Retinal Disease.” Charles, S. and Sullivan, J.P.: Accepted for Publication, Current Science

“The Use of Silicone Oil in Severe Cases of Proliferative Vitreoretinopathy.” Charles, S. and Sullivan, J.P. and Wong, R.V.: In Preparation

“Surgical Removal of Subretinal Neovascular Membranes.” Charles, S. and Sullivan, J.P.: In Preparation

“A Comparison of Anterior Capsulotomy Techniques in Preventing Vitreous Loss With Elevated Posterior Vitreous Pressure.” Presentation. Storm Eye Institute Annual Ophthalmology Update, May, 1992

“The Effects of 2.5% Neosynephrine versus 10% Neosynephrine on Systemic Blood Pressure and Heart Rate.” Presentation, Storm Eye Institute Annual Ophthalmology Update, April, 1991

By Doctor Raul C. Moreno:
“Effect of Succinylcholine on the Intraocular Contents of Open Globes.” Moreno, R.J., Kloess, P., Carlson, D.W.; Ophthalmology 1991, 98: 636-638

“Neuroretinitis: An Unusual Presentation of Ocular Taxoplasmosis. Moreno, R.J., Weisman, J., Waller, S. Accepted for Publication, Annals of Ophthalmology

“Unusual Manifestations of X Linked Juvenile Retinoschisis.” Greven, C.M., Moreno, R.J., Tasman, W. Accepted for Publication, Transactions of the American Ophthalmological Society

“Flurbiprofen Sodium to Prevent Intraoperative Miosis During Vitreoretinal Surgery.” Vander, J.F.,, Greven, C.M., Maquire, J., Moreno, R.J., Shakin, C.P., Lucier, A.C., Amercian Journal of Ophthalmology, 1, 2008: 288-291, 1989

By Doctor William J. Dunn:
“Botulinum Toxin for Dysthyroid Myopathy.” Dunn, W.J., Arnold, A.C., O’Connor, P.S. Ophthalmology, April, 1986, p470-475. Paper presented at American Academy of Ophthalmology Annual Meeting, San Francisco, October 1985

“Choroidal Malignant Melanoma with Early Vitreous Seeding.” Dunn, W.J., Lambert, H.M., Kincaid, M.C., Dieckert, J.P., Shore, J.W. Retina, 1988, Volume 8, Number 3, p 188-192

By Doctor Elias C. Mavrofrides:
Bascom Palmer Grand Rounds. Mavrofrides, E.C.; Co-Editor; Ophthalmology Times. Advanstar Publishing. Cleveland, Ohio, 2003- 2004

“Endophthalmitis Caused by Proteus Species.” Mavrofrides, E.C., Scott, I.U., Flynn, H.W Jr., Miller D. Accepted for publication. Ophthalmology, 2004

“Progression of Familial Exudative Vitreoretinopathy after Laser Treatment.” Couvillion, S.S., Margolis, R.M., Mavrofrides, E.C., Murray, T.G. Accepted for publication. Archives of Ophthalmology, 2004

“Vitreoretinal Interface Disorders.” Mavrofrides, E.C., Rogers, A.H., Truong, S., Puliafito, C.A. In: Schuman, J.S., Puliafito, C.A., Fugimoto, J.G. Optical Coherence Tomography of Ocular Disease, Second Edition. Slack, Inc. Publication pending, 2004

“Central Serous Chorioretinopathy.” Mavrofrides, E.C., Puliafito, C.A. In: Schuman, J.S., Puliafito, C.A., Fugimoto, J.G. Optical Coherence Tomography of Ocular Disease, Second Edition. Slack, Inc. Publication pending, 2004

“Miscellaneous Macular Degeneration.” Mavrofrides, E.C., Puliafito, C.A. In: Schuman, J.S., Puliafito, C.A., Fugimoto, J.G. Optical Coherence Tomography of Ocular Disease, Second Edition. Slack, Inc. Publication pending, 2004

“Macular Degenerations.” Villate, N., Mavrofrides, E.C., Rosenfeld, P. In: Schuman, J.S., Puliafito, C.A., Fugimoto, J.G. Optical Coherence Tomography of Ocular Disease, Second Edition. Slack, Inc. Publication pending, 2004

“Patient Complains of Dimming Vision in Both Eyes- She is referred for Unexplained Vision Loss after Extensive Evaluation is Negative.” Mavrofrides, E.C., Lam, B., Bascom Palmer Eye Institute Grand Rounds, edited by CWG Eifrig, M Benz. Ophthalmology Times, 2003; 28: 14-16, 2003

Baylor Ophthalmology Resident’s Manual: Editor. Baylor College of Medicine, Department of Ophthalmology- Cullen Eye Institute, Houston, Texas, 2001

“ROP Screening and Treatment at Jackson Memorial Hospital/Bascom Palmer Eye Institute Over a 13 month period.” Mavrofrides, E.C., Berrocal, A.M., Hess, D., Johnson, R.A., Murray, T.G. Presented at the Third International Symposium on ROP. Anaheim, California, 2003

“Persistent Neovascularization after Laser Photocoagulation for Threshold Retinopathy of Prematurity.” Mavrofrides, E.C., Berrocal, A.M., Hess, D., Johnson, R.A., Murray, T.G. Presented at the Third International Symposium on ROP. Anaheim, California, 2003

“RetCam Digital Imaging in the Screening and Management of ROP. Mavrofrides, E.C., Berrocal, A.M., Hess, D., Johnson, R.A., Murray, T.G. Presented at the Third International Symposium on ROP. Anaheim, California, 2003

“Endophthalmitis Caused by Proteus Species.” Mavrofrides, E.C., Flynn, H.W. Jr., Scott, I.U., Miller, D. Presented at the Annual ARVO National Meeting. Fort Lauderdale, Florida, 2003

“Pilot Study of Intravitreal Injection of Tiamcinolone Acetonide for Refractive Diabetic Macular Edema.” Park, P.W., Mavrofrides, E.C., Holz, E.R., Mieler, W.F. Presented at the Annual ARVO National Meeting. Fort Lauderdale, Florida, 2003

“Intravitreal Triamcinolone for Refractory Diabetic Macular Edema.” Mavrofrides, E.C., Bailey, K., Holz, E.R., Mieler, W.F. Presented at the Baylor Ophthalmology Alumni Association Annual Meeting. Houston, Texas, 2002

“Lasik for the Treatment of Mixed Astigmatism-Visual Outcomes and Topographic Analysis.” Mavrofrides, E.C., Wang, N., Wang, L, Koch D.D. Presented at the Baylor Ophthalmology Alumni Association Annual Meeting. Houston, Texas, 2001

“Ocular Agyrosis – A Case Report and Literature Review.” Mavrofrides, E.C., Wilhelmus, K.R. Presented at the Baylor Ophthalmology Alumni Association Annual Meeting. Houston, Texas, 2000